Cargando…
BRCA1: An Endocrine and Metabolic Regulator
The breast and ovarian cancer susceptibility gene (BRCA1) is a tumor suppressor whose mutation has been associated with the development of breast, ovarian and, probably, other malignancies at young ages. The BRCA1 gene product participates in multiple biological pathways including the DNA damage res...
Autor principal: | Werner, Haim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009035/ https://www.ncbi.nlm.nih.gov/pubmed/35432218 http://dx.doi.org/10.3389/fendo.2022.844575 |
Ejemplares similares
-
Editorial: DNA damage response pathways meet endocrine systems
por: Werner, Haim, et al.
Publicado: (2023) -
Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer
por: Cohen-Sinai, Tali, et al.
Publicado: (2017) -
Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer
por: Bhattacharya, Debasmita, et al.
Publicado: (2019) -
Editorial: Endocrine Disrupters and Metabolism
por: Gibert, Yann, et al.
Publicado: (2019) -
Editorial: Multifaceted Cannabinoids: Regulators of Normal and Pathological Function in Metabolic and Endocrine Organs
por: Szanda, Gergő, et al.
Publicado: (2022)